XenoTherapeutics, Inc. and Xeno Acquisition Corp. acquires Repare Therapeutics

XenoTherapeutics, Inc. and Xeno Acquisition Corp. agreed to acquire Repare Therapeutics. Reported deal value: Undisclosed. Status: Completed. Sector: Biotechnology. Target headquarters context: Montreal, Quebec, Canada.

This page summarizes publicly available information about the transaction as of 2026-01-29. Figures and status may change as filings and press coverage update.

On January 28, 2026, Repare Therapeutics completed its acquisition by non-profit biotechnology group Xeno Therapeutics , Inc. and Xeno Acquisition Corp. via a statutory plan of arrangement, following shareholder approval on January 16, 2026 and a final court order from the Superior Court of Québec on January 23, 2026